Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Hemolytic Anemia, Hemoglobinopathy, and Congenital Hemolytic Anemia.

Dr. Lydia H. Pecker is a pediatric hematologist and Director of the Young Adult Clinic at the Sickle Cell Center for Adults at Johns Hopkins. Dr. Pecker received her undergraduate degree in Africana studies from Brown University and earned her M.D. at the University of Pennsylvania School of Medicine. She completed residency training at Children’s Hospital at Montefiore and completed a fellowship at Children’s National Medical Center and the National Institutes of Health’s National Heart, Lung and Blood Institute before joining the Hopkins faculty in 2016. Dr. Pecker's NIH and foundation-funded research focuses on reproductive health in people with ovaries and sickle cell disease. Dr. Pecker is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Tubal Ligation, and Bone Marrow Transplant.

"Dr. James Casella is a professor of pediatrics and oncology at the Johns Hopkins University School of Medicine. As the Johns Hopkins’ Rainey Professor of Pediatric Hematology, Dr. Casella is chief of the Division of Pediatric Hematology at Johns Hopkins Children's and director of the Basic and Translational Research Program in Sickle Cell Disease, Comprehensive Sickle Cell Center and the Maryland Hemophilia Treatment Center at Johns Hopkins. He supervises several labs investigating the cellular and molecular basis of pediatric blood-borne diseases. He is seeking to develop better treatments for sickle cell disease and the prevention of central nervous system complications of this disorder, including stroke. Dr. Casella received his undergraduate degree in mathematics from Union College. He earned his M.D. from SUNY of Syracuse and completed a residency in pediatrics at Johns Hopkins University School of Medicine, where he was subsequently a fellow in hematology/oncology. He has been a member of the Johns Hopkins’ faculty since 1983. A research scientist as well as a clinician, he co-directs the hematology/oncology fellowship program at Johns Hopkins Hospital and is an adjunct senior investigator (Pediatric Oncology Branch) in the Division of Clinical Sciences, National Cancer Institute, National Institutes of Health. He is also director of the NHLBI-funded K12 in benign hematology program at Johns Hopkins that trains young clinician/investigators in benign hematology and transfusion medicine. Dr. Casella has served on numerous university, hospital, and advisory committees, many geared toward hematology, pediatrics and transfusion. He has received many awards from the Johns Hopkins Hospital, including the Alexander ""Buck"" Schaffer Award for Outstanding Contribution to the Teaching of House Officers. He and a colleague created the Johns Hopkins/St. Agnes Comprehensive Hemophilia Clinic to improve care for patients with the disease.". Dr. Casella is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

John Tisdale is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Tisdale is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Anemia.

Courtney Fitzhugh is a Hematologist in Baltimore, Maryland. Dr. Fitzhugh is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.

Jennie Law is a Hematologist in Baltimore, Maryland. Dr. Law is rated as an Elite provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Hemoglobin SC Disease, Hemoglobin E Disease, and Bone Marrow Aspiration.

Maria Baer is a Hematologist in Baltimore, Maryland. Dr. Baer is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Splenectomy.

Dr. Li Hua is a hospitalist at Johns Hopkins Howard County Medical Center. Dr. Hua only sees patients who are in the hospital, she does not have outpatient clinic appointments. Dr. Hua is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Sepsis, Ogilvie Syndrome, Hip Replacement, and Gastrostomy.

Dr. Jenna V. Canzoniero is an assistant professor in the Breast and Gynecological Malignancies Group at the Johns Hopkins Sidney Kimmel Cancer Center. She is a medical oncologist who specializes in treatment of patients with breast cancer. Dr. Canzoniero earned her medical degree and master's in bioinformatics from University of Michigan. She completed internal medicine residency at University of Maryland and served as Chief Resident. She joined the faculty at Johns Hopkins as an academic Hospitalist before pursuing her passion for oncology. She completed medical oncology fellowship at Johns Hopkins, including serving as Chief Fellow, and then re-joined the faculty as an oncologist. Her research focuses on expanding the use of molecular diagnostics, including liquid biopsy, to guide the treatment for patients with breast cancer. She is the liquid biopsy leader for the Johns Hopkins Molecular Tumor Board and leads the precision medicine initiative for the Breast and Gyn Malignancies Group. Previous awards include Director's Teaching Award in Clinical Science (2023) and the Marion Wright Award for Scientific Excellence (2024) from the Breast Cancer Research Fund. Dr. Canzoniero is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, BRCA Positive Breast Cancer, Breast Cancer, Hemoglobin E Disease, and Gastrostomy.

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

Gayatri Nimmagadda is a Hematologist and a Hematologist Oncology provider in Columbia, Maryland. Dr. Nimmagadda is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Pleuropulmonary Blastoma.

Dr. Benjamin Bodnar is an Assistant Professor of Medicine and Pediatrics at the Johns Hopkins School of Medicine. He holds appointments as the Director of Quality and Safety for the Division of Hospital Medicine, Department of Medicine, as a Eudowood Scholar of Quality and Safety in the Division of Quality and Safety, Department of Pediatrics, and is affiliate faculty with the Armstrong Institute for Patient Safety and Quality at Johns Hopkins. He was born and raised in Baltimore and after training in institutions across the country, and working at sites around the world, he has settled back in his hometown. He received his undergraduate degree from Stanford University, his medical degree from Columbia University, and completed his specialty training at Yale New Haven Hospital. He also worked at Brigham and Women’s Hospital in Boston, MA, and held the appointment of an Instructor in Medicine at Harvard Medical School prior to joining Johns Hopkins in 2016. His focus on providing world-class clinical care to his patients at Johns Hopkins Hospital, he has a special interest in global health and the application of Quality Improvement techniques to the often poorly functional systems at work in resource-limited and developing health care environments. He has worked internationally at sites including Nepal, Mongolia, Ghana, Tanzania, Uganda, and Rwanda, and has worked with development groups including Partners in Health and The Millennium Villages Project. He is a faculty member of the Johns Hopkins Center for Global NCD Research and Training. As part of the Johns Hopkins Medicine COVID-19 response, he led the creation of standardized patient care guidelines for non-ICU COVID-19 patients across the health system. He also played a key role in the implementation of these guidelines via an Electronic Medical Record-integrated Clinical Decision Support platform, thus ensuring the evolving guidance is available to all providers at the point of care. Dr. Bodnar is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Hemoglobin C Disease, Hemoglobinopathy, Endoscopy, and Gastrostomy.

Swee Thein is a Hematologist in Bethesda, Maryland. Dr. Thein is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Anemia.

Jennifer Webb is a Hematologist and an Oncologist in Silver Spring, Maryland. Dr. Webb is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Hemolytic Anemia, Anemia, Bone Marrow Transplant, and Splenectomy.

Matthew Hsieh is a Hematologist in Bethesda, Maryland. Dr. Hsieh is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Hemolytic Anemia, Anemia, and Bone Marrow Transplant.

Tara Robinson is a Hematologist in Baltimore, Maryland. Dr. Robinson is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Hemoglobin SC Disease, Hemoglobinopathy, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.

Sajeev Anand is a Hematologist in Greenbelt, Maryland. Dr. Anand is rated as a Distinguished provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Myelodysplastic Syndrome (MDS), Adult Immune Thrombocytopenia, and Immune Thrombocytopenic Purpura (ITP).

Fatima Syed is a primary care provider, practicing in Hospital Medicine in Columbia, Maryland. Dr. Syed is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. Her top areas of expertise are Sickle Cell Disease, Brain Abscess, Epidural Abscess, Sepsis, and Pacemaker Implantation.

Dr. Henry Michtalik is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include internal medicine. Dr. Michtalik earned his M.D. from Albany Medical College of Union University. He completed his residency at the University of Miami School of Medicine and performed a fellowship in internal medicine at Johns Hopkins. His research interests include patient safety issues, especially as related to patient census and transitions of care from acute to primary care, and quality improvement and systems management. Dr. Michtalik was recognized in 2013 as one of the top hospitalists by ACP Hospitalist journal. Dr. Michtalik is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Sickle Cell Disease, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Joseph Zebley is a primary care provider, practicing in Family Medicine in Baltimore, Maryland. Dr. Zebley is rated as an Advanced provider by MediFind in the treatment of Sickle Cell Disease. His top areas of expertise are Hemoglobinopathy, Hemoglobin E Disease, Hemoglobin C Disease, and Hemoglobin SC Disease.